[(1-isobutyl-1H-imidazol-5-yl)methyl]amine dihydrochloride, 95.0%, 5g

3,4,5-trimetossi-benzaldeide, minimo 98%, 25 g, confezione in vetro

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 98%, 5g

Methyl 4-bromo-2-(methylthio)benzoate, 95%, 500mg

Pisiferic Acid>98.0%(HPLC)100mg

Ethyl 2-Bromovalerate>98.0%(GC)100g

8-Bromooctanoic acid, 97%, 10g

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole, 97%, 250mg

beta-Methyllevulinic Acid>98.0%(GC)(T)25g

N-Cyclopropyl-4-methylbenzenesulfonamide, 97%, 5g

tert-Butyl 7-hydroxy-5-thia-2-azaspiro[3.4]octane-2-carboxylate, 97%, 250mg

N,N'-(Hexane-1,6-diyl)bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide), 97%, 5g

Ethyl 2-bromo-3-methylbenzoate, 1g